Andhra Medi Pharma India Pvt. Ltd.

The performance of a company depends heavily on its suppliers. Therefore, a reliable network of partners (suppliers, dealers and manufacturers) is elementary. In bills of lading, a total of 2 international suppliers of Andhra Medi Pharma India Pvt. Ltd. could be identified on which the company is relying. One of the suppliers is, for example, the company Stauber Ingredients, which delivered 1 shipment.

Get an overview of Andhra Medi Pharma India Pvt. Ltd.’s international procurement and its 2 suppliers with Company Transparency

Generally you can differentiate the supply chain or supply network of Andhra Medi Pharma India Pvt. Ltd. by two perspectives:

• The supplier side (a so-called Tier-1-supplier is a direct supplier, Tier-2 is a supplier of the Tier-1 supplier, Tier-n is a supplier at any level in the Andhra Medi Pharma India Pvt. Ltd. supply network).
• The buyer side (a so-called Tier-1 buyer is a direct buyer, Tier-2 is a buyer of the Tier-1 buyer, Tier-n is a buyer at any level in the Andhra Medi Pharma India Pvt. Ltd. distribution network).

To ensure business stability and continuity, a supply chain or supply network must be constructed in such a way that external influences can cause as little damage as possible to Andhra Medi Pharma India Pvt. Ltd.. This applies both in the area of procurement (the loss of a supplier must be covered by an alternative supplier) as in the area of sales (the loss of a buyer must be covered by an alternative buyer).

Risks can generally be considered as the non-availability of goods, through cutback or complete halt of production, or the potential loss of business partners, violating compliance rules (e.g. protection of the environment, labor legislation) and thus drop out of the supply network.

This risk should not necessarily be limited to the direct business partner (Tier 1), it involves the entire supply chain, unless sufficient alternative suppliers and buyers have been put in place.

Get an overview of the international supply chain of Andhra Medi Pharma India Pvt. Ltd. (upstream/procurement and downstream/sales) from Tier-1 to Tier-n

E.G.: Tier 1 supplier Stauber IngredientsTier-1 Buyer Buckton Scott Deutschland GmbH

ABRAMS world trade wiki not only shows direct suppliers and customers of the first tier (Tier-1). With just one click in our tool Supply Chain Intelligence you get a comprehensive insight into the supply network with multiple tiers (Tier-n) beyond the first tier.

Each tier in the supply chain or supply network on the supplier side of Andhra Medi Pharma India Pvt. Ltd. involves a single risk. The more tiers, the more difficult it is to analyze and monitor the business partners. Suppliers of suppliers are generally unknown, so there is already an increasing risk at the second (Tier 2) level.

If e.g. a first Tier supplier is not adding any value, the supply chain can be shortened and the risk of failure can be minimized by skipping this supplier. A previous Tier-2 supplier now turns into a Tier-1 supplier, which we call "go-direct". In our tool Supply Chain Intelligence as far as international suppliers are concerned, this analysis can be done with one click:

Analyze the potential of shortening and therefore stabilizing the supply chain of Andhra Medi Pharma India Pvt. Ltd.

Based on the analysis of international bills of lading (bill of lading/ bills of lading/ BOL), a total of 3 different product categories that have been purchased by Andhra Medi Pharma India Pvt. Ltd., can be identified.

These are classified by means of HS codes (HTS codes or customs tariff numbers).

For example, HS code 902790 classifies the following products:

„Microtomes; parts and accessories of instruments and apparatus for physical or chemical analysis, instruments and apparatus for measuring or checking viscosity, porosity, expansion, surface tension or the like, instruments and apparatus for measuring or checking quantities of heat, sound or light, and of microtomes, n.e.s.". This HS code was sighted 2 times in total.

Get an overview of internationally purchased products by Andhra Medi Pharma India Pvt. Ltd. with Company Transparency

Each tier in the supply chain or supply network of Andhra Medi Pharma India Pvt. Ltd. is adding value and therefore costs. The more tiers, the more expensive the product gets. Supply chains are normally not very transparent, trade secrets are part of the survival tactics in each stage of the value chain, especially for trading companies.

If e.g. a Tier-1 supplier from Andhra Medi Pharma India Pvt. Ltd. that primarily trades a product and doesn’t add any value (only fulfills the distributor function) it is possible to shorten the supply chain and reduce purchasing costs. A previous Tier-2 supplier now turns into a Tier-1 supplier, which we call "go-direct". In our tool Supply Chain Intelligence as far as international suppliers are concerned, this analysis can be done with one click:

Analyze the potential of shortening the supply chain of Andhra Medi Pharma India Pvt. Ltd. and saving costs on the procurement side.

The performance of a company depends fundamentally on its buyers. Therefore, a largest possible base of stable buyers is crucial. A total of 102 international buyers of Andhra Medi Pharma India Pvt. Ltd. could be identified in bills of lading. For example, one of the buyers is the company Buckton Scott Deutschland GmbH, which has received 16 shipments.

Among 10 identified buying countries, an important target country to sell products to is: United States of America. 48 shipments of goods were shipped to this country in the period covered.

Get an overview of the international sales and its 102 buyers of Andhra Medi Pharma India Pvt. Ltd. with Company Transparency.

Based on the analysis of international bills of lading (bill of lading/ bills of lading/ BOL), a total of 2 different product categories sold by Andhra Medi Pharma India Pvt. Ltd., can be identified.

These are classified by means of HS codes (HTS codes or customs tariff numbers).

For example, HS code 293299 classifies the following products:

„Heterocyclic compounds with oxygen hetero-atom[s] only (excl. compounds containing unfused furan ring, whether or not hydrogenated, in the structure, and lactones, isosafrole, 1-[1,3-benzodioxol-5-yl]propan-2-one, piperonal, safrole, tetrahydrocannabinols "all isomers", and inorganic or organic compounds of mercury)". This HS code was sighted 403 times in total.

From the product descriptions of the analyzed bills of lading (bill of lading/ bills of lading/ BOL), the following products sold to various buyers can be identified as an example:

Get an overview of internationally sold products by Andhra Medi Pharma India Pvt. Ltd. with Company Transparency

Each tier in the buyer side of the supply chain or supply network of Andhra Medi Pharma India Pvt. Ltd. is adding value and therefore costs. The more tiers, the more expensive the product gets. Supply chains are normally not very transparent, trade secrets are part of the survival tactics in each stage of the value chain, especially for trading companies.

If e.g. a Tier-1 buyer from Andhra Medi Pharma India Pvt. Ltd. that primarily trades products and doesn’t add any value (only fulfills the distributor function) it is possible to shorten the supply chain downstream giving a potential to optimize profit margins for Andhra Medi Pharma India Pvt. Ltd.. A previous Tier-2 buyer now turns into a Tier-1 buyer, which we call "go-direct". In our tool Supply chain Intelligence as far as international buyers are concerned, this analysis can be done with one click:

Analyze the potential to shorten the supply chain and optimize the profit margins on the sales side of Andhra Medi Pharma India Pvt. Ltd.

Each company contributes significantly minimizing risks for its buyers, through its own stability. Internal risks (endogenous factors) can be e.g. financially (financial ratios, free cash flow, balance sheets) or operationally (production, lead times). Since 2021, external risks have increased due to worldwide shortages and are an important factor as to whether a supplier such as Andhra Medi Pharma India Pvt. Ltd. can itself reliably deliver due to external dependencies (exogenous factors).

To assess this, data analysis should be conducted to get practical answers:

How is the supply chain or supply network structured on the supplier side of Andhra Medi Pharma India Pvt. Ltd.? Are there suppliers or products in the supply chain that are reported as critical, e.g. in international media?

Which buyers does Andhra Medi Pharma India Pvt. Ltd. consistently sell to over a long period of time that can be identified as a good reference?

The more constant outgoing shipments of a company’s, the easier it is to assess potential problems for a supplier like Andhra Medi Pharma India Pvt. Ltd.

Operational aspects like a stable supply chain, an in-house production and reliable logistics define sustainable performance.

Since 2021, global supply shortages have increasingly added external factors as to whether a supplier like Andhra Medi Pharma India Pvt. Ltd. can deliver reliably itself through dependencies.

Based on the statistical trend of shipments (in terms of the number of shipments and respectively the quantity of goods) the current supply and performance capacity can be indirectly analyzed.

Here you can see an analysis of shipments by Andhra Medi Pharma India Pvt. Ltd. to international buyers in the last few months with Company Transparency

The more constant incoming shipments, the better one can determine possible procurement problems of a company like Andhra Medi Pharma India Pvt. Ltd.

Since 2021, there are increasingly external factors due to global supply shortages, whether a company, no matter manufacturer or distributor, can reliably deliver through dependencies.

Based on the statistical trend of shipments (in terms of the number of shipments and respectively the quantity of goods) it is possible to analyze current procurement stability and thus ultimately also to derive an indication of the company’s delivery and performance capability.

Generally you can differentiate the competition of Andhra Medi Pharma India Pvt. Ltd. by the purchase and sales perspective.

• Start the competitive analysis on the purchase side.
• Start the competitive analysis on the sales side.

Competitors of Andhra Medi Pharma India Pvt. Ltd. on the purchase side (procurement of raw materials and components for production or distribution) are exposed on ABRAMs wiki under Competitive Intelligence, purchased products, classified by HS-Codes (e.g. 902790, 293299) or by top product terms.

Competitors on the sales side of Andhra Medi Pharma India Pvt. Ltd. (selling raw materials or components for production or distribution) are exposed on ABRAMS wiki under Competitive Intelligence, sold products classified by HS-Codes (e.g. 293299, 2942) or by top product terms.